The Valley Desk

NCT01024946 · Interventional trial

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

Overall registry status Completed

Phase 2

Conditions Malignant Pleural Mesothelioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov